相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。68Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy and PSA <0.5 ng/ml. Efficacy and impact on treatment strategy
Andrea Farolfi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Ga-68-PSMA 11 ligand PET imaging in patients with biochemical recurrence after radical prostatectomy - diagnostic performance and impact on therapeutic decision-making
B. Grubmueller et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Impact of 68Ga-Prostate-Specific Membrane Antigen PET/CT on Prostate Cancer Management
Asim Afaq et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
68Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning
Jeremie Calais et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Immunohistochemical Validation of PSMA Expression Measured by Ga-68-PSMA PET/CT in Primary Prostate Cancer
Nadine Woythal et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Efficacy, Predictive Factors, and Prediction Nomograms for Ga-68-labeled Prostate-specific Membrane Antigen-ligand Positron-emission Tomography/Computed Tomography in Early Biochemical Recurrent Prostate Cancer After Radical Prostatectomy
Isabel Rauscher et al.
EUROPEAN UROLOGY (2018)
Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations
Jeffrey J. Tosoian et al.
NATURE REVIEWS UROLOGY (2017)
68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0
Wolfgang P. Fendler et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Estimating the incidence of oligorecurrent and potentially salvageable prostate cancer on 18F-Choline PET-CT: Screening phase of the STOMP randomized phase II trial.
Piet Ost et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Treatment Outcomes from 68Ga-PSMA PET/CT-Informed Salvage Radiation Treatment in Men with Rising PSA After Radical Prostatectomy: Prognostic Value of a Negative PSMA PET
Louise Emmett et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
68Ga-PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment
Pim J. van Leeuwen et al.
BJU INTERNATIONAL (2016)
68Ga-PSMA I&T PET/CT for assessment of prostate cancer: evaluation of image quality after forced diuresis and delayed imaging
Thorsten Derlin et al.
EUROPEAN RADIOLOGY (2016)
Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis
Marlon Perera et al.
EUROPEAN UROLOGY (2016)
Improved Metastasis-Free and Survival Outcomes With Early Salvage Radiotherapy in Men With Detectable Prostate-Specific Antigen After Prostatectomy for Prostate Cancer
Bradley J. Stish et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy
Rahul D. Tendulkar et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
OLIGOPELVIS - GETUG P07: a multicentre phase II trial of combined salvage radiotherapy and hormone therapy in oligometastatic pelvic node relapses of prostate cancer
Stephane Supiot et al.
BMC CANCER (2015)
Metastasis-directed Therapy of Regional and Distant Recurrences After Curative Treatment of Prostate Cancer: A Systematic Review of the Literature
Piet Ost et al.
EUROPEAN UROLOGY (2015)
Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy
Matthias Eiber et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Stereotactic body radiotherapy for oligometastases
Alison C. Tree et al.
LANCET ONCOLOGY (2013)
Adjuvant Versus Salvage Radiotherapy for High-Risk Prostate Cancer Patients
Christopher R. King
SEMINARS IN RADIATION ONCOLOGY (2013)
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
Andrew J. Stephenson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
分享论文
